CFD's zijn complexe instrumenten en gaan gepaard met een hoog risico snel kapitaal te verliezen als gevolg van hefboommechanismen. 77.3% an de retailbeleggers lijdt verlies op de handel in CFD's met deze aanbieder. U dient zorgvuldig te overwegen of u begrijpt hoe CFD's werken en of u het zich kunt veroorloven om hoge risico's te nemen op het verliezen van uw kapitaal.

Close

Handelen AbbVie ABBV

AbbVie live grafieken

instrument_fundamentals

Weekly Search
Weekly
Daily
Datum Sluit Verandering % verandering Openen Piek Bodem

AbbVie news

Tommy Yap 2025 Apr 19, 16:00

Week Ahead: Growth, Inflation, and Consumer Trends in Focus

Forex Indices
Federal Reserve Rate Decision 
Darius Anucauskas 2025 Jan 25, 16:00

Week Ahead: China Is On Holiday, But The BoC, The Fed, And The ECB Will Be Busy With The First 2025 Rate Announcements 

Forex Indices
Magnificent 7 earnings, US and Japan inflation due next week
Neil Wilson 2024 Jul 18, 16:00

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Forex Indices
Wall Street earnings
Neil Wilson 2023 Oct 20, 10:00

Week ahead: Earnings bonanza, ECB decision & US inflation

Forex Indices
Neil Wilson 2023 Jul 21, 00:09

Week ahead: Fed, ECB & BoJ in action

Forex Indices

Laatste marktnieuws

Toon meer
Ghko B 2025 Jun 10, 16:00

BTC USD Price Prediction: How much will Bitcoin be worth in 2030?

Cryptocurrencies
Ghko B 2025 Jun 10, 16:00

Wells Fargo Stock Slides 1.32%: Is Wells Fargo stock a good buy now?

Stocks
Tommy Yap 2025 Jun 10, 16:00

Morning Note: U.S. CPI, Japan Inflation Shape Market Expectations Today

Morning Note USD JPY S&P 500
Darius Anucauskas 2025 Jun 10, 16:00

Morning Note: Trade Truce, CPI Data Put Fed and Markets in Spotlight

Morning Note DJIA CPI Forex
Ghko B 2025 Jun 09, 16:00

Latest 2025 BTC Price Predictions: Will Bitcoin Hit $150K?

Cryptocurrencies
Ghko B 2025 Jun 09, 16:00

Most Active Japanese Stocks: SONY, TAK, HMC, Toyota Motor, TOELY

Stocks
Darius Anucauskas 2025 Jun 09, 16:00

Morning Note: UK Job Weakness Meets Rising Oil Hopes from China US Talks

Morning Note Oil GBP BoE Forex
Tommy Yap 2025 Jun 09, 16:00

Morning Note: Trump Sticks with Starlink as Markets Await UK Job Data

Morning Note Oil GBP TSLA

Info

Spread

1.20

Spread (%)

0.6296 %

Hefboom

1:5

Dagrente kopen

-0.0597 %

Dagrente verkopen

-0.0292 %

Valuta

USD

Openingstijden

Markt gesloten

Donderdag

13:31 - 19:59

Maandag

13:31-19:59

Dinsdag

13:31-19:59

Woensdag

13:31-19:59

Vrijdag

13:31-19:59

instr__analysis_statistics

Openen

---

Vorige Sluiten

---

52-weekse hoog/laag

--- – ---

Beurswaarde

334732787712

Uitstaande aandelen

1766400000

Datum winstcijfer (volgende)

0000-00-00

Div. rend.

2025-05-15

Ex-dividenddatum

2025-04-15

Jaarlijks verwachte dividendpercentage

6.56

Jaarlijks verwachte dividendrendement

0.0347

Winst per aandeel

2.35

Meer informatie over dit instrument

AbbVie AbbVie Inc
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Gerelateerde instrumenten

Activa
Verkoop
Koop
% verandering
Gerelateerde instrumenten

latest_education_articles

Toon meer
Trustpilot